Hospital reimbursement price cap for cancer drugs: The french experience in controlling hospital drug expenditures

PharmacoEconomics

Volumn 30, Issue 7, 2012, Pages 565-573

  Degrassat Thas, A ^a   Bensadon, M ^b   Rieu, C ^c   Angalakuditi, M ^d   Le Pen, C ^a   Paubel, P ^c  

^a UNIVERSITÉ PARIS DAUPHINE   (France)

^b Technical Agency of Information on Hospitals (ATIH)   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d EISAI INC   (United States)

Author keywords

Branded drugs; Cancer; Generic drugs; Health policy; Healthcare expenditure; Pricing.

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; GEMCITABINE; GENERIC DRUG; IRINOTECAN; NAVELBINE; OXALIPLATIN; PACLITAXEL; RITUXIMAB; TRASTUZUMAB;

ARTICLE; COST CONTROL; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG USE; FRANCE; GROWTH RATE; HEALTH CARE POLICY; HOSPITAL; HUMAN; PRIORITY JOURNAL; REIMBURSEMENT; TRADE UNION;

ALGORITHMS; ANTINEOPLASTIC AGENTS; COST CONTROL; DATA INTERPRETATION, STATISTICAL; DRUG COSTS; ECONOMICS, HOSPITAL; FRANCE; HUMANS; REIMBURSEMENT MECHANISMS;

EID: 84862195362     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11588320-000000000-00000     Document Type: Article

References (10)

1. Organisation for Economic Co-operation and Development. Pharmaceutical pricing policies in a global market:executive summary. Paris:OECD, 2008 [online]. Available from URL:http://www.oecd.org/dataoecd/36/2/41303903.pdf [Accessed 2009 Dec 10]
2. Fenina A, Le Garrec M-A, DuéeM. Les comptes nationaux de la santé en 2008. É tudes et Ré sultats 2009 Sep; 701:1-4
3. Financing of Social Security Act for 2004 of 18 December 2003 [in French], loi no. 2003-1199. Journal Officiel de la République Française 2003 Dec 19; 293:21641
4. International Monetary Fund. Producer price Index manual:glossary [online]. Available from URL:http://www. imf.org/external/np/sta/tegppi/index. htm [Accessed 2010 Aug 30]
5. Clerc M-E. Les dépenses de médicaments remboursables en 2007. É tudes et Ré sultats 2008 May; 634:1-8
6. Clerc M-E, Haury B, Rieu C. Les médicaments hors tarification a l'activité dans les établissements de santé. É tudes et Ré sultats 2008 Aug; 653:1-8
7. Institut National du Cancer. Chimiothérapie et thérapie cible ́es [online]. Available from URL:http://www.e-cancer.fr/ soins/les-traitements/chimiotherapie [Accessed 2012 Apr 26]
8. Cour des Comptes. La dépense de medicaments:rapport - la sécurité sociale, Septembre 2007 [online]. Available from URL:http://www.ladocumentationfrancaise.fr/rapportspublics/ 074000560/index. shtml [Accessed 2009 Dec 10]
9. Currier KM, Jackson BK. A pedagogical note on the superiority of price-cap regulation to rate-of-return regulation. J Econ Edu 2008; 3:261-86
10. Amory A, Benizri F, Paubel P. Évolution des dépenses de médicaments facturables en sus des prestations d'hospitalisation en Ile-de-France. Revue Hospitaliere de France 2006 Sep-Oct; 512:69-71